Enhanced O-GlcNAcylation Mediates Cytoprotection under Proteasome Impairment by Promoting Proteasome Turnover in Cancer Cells

Summary: The proteasome is a therapeutic target in cancer, but resistance to proteasome inhibitors often develops owing to the induction of compensatory pathways. Through a genome-wide siRNA screen combined with RNA sequencing analysis, we identified hexokinase and downstream O-GlcNAcylation as cell...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Eiichi Hashimoto, Shota Okuno, Shoshiro Hirayama, Yoshiyuki Arata, Tsuyoshi Goto, Hidetaka Kosako, Jun Hamazaki, Shigeo Murata
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2020-07-01
Serie:	iScience
Soggetti:	Biological Sciences Cell Biology Functional Aspects of Cell Biology Cancer
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2589004220304867
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!